2024年11月6日上午，在中国国际进口博览会现场，爱施健中国宣布与浙江圣兆药物科技股份有限公司（以下简称“圣兆药物”）正式签署合作意向书，双方约定就布比卡因脂质体注射液开展商业化合作，并将尽快签署正式的合作协议。爱施健中国首席执行官Larry ...

The No Pain Act will mandate Medicare insurance coverage for non-opioid pain management, including evidence-based treatments, ...

Final CMS rule concludes iovera is a qualifying device for separate payment under the NOPAIN Act ---- Beginning January 1, 2025, providers can ...

When the catheter is secured in place, the investigator applies bupivacaine solution to the wound before surgically closing it. Then, she tapes a piece of absorbent paper towel or gauze over the ...

Droperidol was a first-line, highly effective agent for the treatment of PONV for over 30 years. It has the most postmarketing surveillance data of any of the currently used antiemetic agents.

Through his work as a clinical fellow in paediatric surgery at the University Hospital Southampton NHS Foundation Trust, he ...

In 2015 Siddiqui was struck off the General Medical Council Register after a panel of the Medical Practitioners Tribunal Service found him guilty failures in performing non-therapeutic male ...

PCRX reports mixed third-quarter 2024 results, wherein earnings beat estimates but revenues miss. Exparel sales witness year-over-year growth.

Pacira ended the third quarter of 2024 with cash, cash equivalents and available-for-sale investments (“cash”) of $453.8 million. Cash provided by operations was $53.9 million in the third quarter of ...